Global Hybrid Imaging Market 2017-2021

  • ID: 4115467
  • Report
  • Region: Global
  • 91 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AGFA Healthcare
  • Carestream Health
  • Cubresa
  • IBA Molecular
  • Nordion
  • Piramal Imaging
  • MORE
About Hybrid Imaging

Hybrid imaging refers to the fusion or combination of one or more imaging modalities to form an innovative technique. Hybrid imaging modalities that are now in existence include single photon emission computed tomography (SPECT)/CT, positron emission tomography (PET)/CT, and PET/MR imaging. Most of these modalities have the potential to aid the development of personalized, molecular medicine. These technologies help detect and evaluate various disorders in the areas of oncology, cardiology, and neurology.

The analysts forecast the global hybrid imaging market to grow at a CAGR of 8.01% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global hybrid imaging market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various hybrid imaging systems to key end-users, such as hospitals, diagnostic centers, and ambulatory centers.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Hybrid Imaging Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- GE Healthcare
- Mediso
- Philips Healthcare
- Siemens Healthcare

Other prominent vendors
- Advanced Accelerator Applications
- AGFA Healthcare
- BC Technical
- Cardinal Health
- Carestream Health
- CMR Naviscan
- Cubresa
- Eczacibasi-Monrol Nuclear Products
- FUJIFILM Holdings
- IBA Molecular
- Mylin Medical
- CMR Naviscan
- Nordion
- Photo Diagnostic Systems
- Piramal Imaging
- Positron
- RadioMedix
- Roses Medical & Surgical Supply
- Sofie Biosciences
- Toshiba Medical Systems

Market drivers
- Functional and anatomic imaging capability expanding clinical application of hybrid imaging.
- For a full, detailed list, view the full report

Market challenges
- Shortage of skilled physicians coupled with extensive training facilities.
- For a full, detailed list, view the full report

Market trends
- Growing research activities to widen applications of hybrid imaging.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AGFA Healthcare
  • Carestream Health
  • Cubresa
  • IBA Molecular
  • Nordion
  • Piramal Imaging
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Market snapshot

PART 05: Market landscape

Market overview

Five forces analysis

PART 06: Market segmentation by product type

PET/CT

SPECT/CT

PET/MRI

PART 07: Market segmentation by application

Oncology

Cardiology

Neurology

Others

PART 08: Geographical segmentation

Hybrid imaging market in Americas

Hybrid imaging market in EMEA

Hybrid imaging market in APAC

PART 09: Market drivers

Increasing prevalence of chronic disorders

Growing adoption of PET/CT hybrid imaging

Limitations involved in individual imaging systems

Functional and anatomic imaging capability expanding clinical application of hybrid imaging

PART 10: Impact of drivers

PART 11: Market challenges

High-cost of hybrid imaging devices coupled with limited reimbursements

Shortage of skilled physicians coupled with extensive training requirements

Competition from other imaging modalities

Patient safety issues due to radiation exposure

PART 12: Impact of drivers and challenges

PART 13: Market trends

Increasing focus on developing PET/MR hybrid imaging systems

Emergence of time of flight-hybrid image systems

Growing research activities to widen applications of hybrid imaging

Rising focus in emerging economies

PART 14: Vendor landscape

Competitive scenario

Key news

PART 15: Key vendor analysis

GE Healthcare

Mediso

Philips Healthcare

Siemens Healthcare

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Snapshot of global hybrid imaging market
Exhibit 03: Global hybrid imaging market 2016-2021 ($ millions)
Exhibit 04: Global hybrid imaging market analysis: Developed and emerging markets
Exhibit 05: Five forces analysis
Exhibit 06: Global hybrid imaging market: Segmentation by product type
Exhibit 07: Global hybrid imaging market: Segmentation by product type 2016 & 2021
Exhibit 08: Global hybrid imaging market: Segmentation by product type 2016
Exhibit 09: Global hybrid imaging market: Lifecycle analysis 2016
Exhibit 10: Benefits and risks of PET/CT hybrid imaging
Exhibit 11: Current applications of hybrid PET/CT imaging 2016
Exhibit 12: Global PET/CT hybrid imaging market 2016-2021 ($ millions)
Exhibit 13: Current applications of hybrid SPECT/CT imaging 2016
Exhibit 14: Global SPECT/CT hybrid imaging market 2016-2021 ($ millions)
Exhibit 15: Global PET/MRI hybrid imaging market 2016-2021 ($ millions)
Exhibit 16: Global hybrid imaging market segmentation by product type 2016-2021 ($ millions)
Exhibit 17: Global hybrid imaging market segmentation by product type 2016-2021 (%)
Exhibit 18: Global hybrid imaging market impact analysis 2016-2021
Exhibit 19: Global hybrid imaging technology segmentation by application type
Exhibit 20: Hybrid imaging market segmentation by geography 2016-2021(%)
Exhibit 21: Hybrid imaging market segmentation by geography 2016
Exhibit 22: Hybrid imaging market segmentation by geography 2016: Lifecycle analysis
Exhibit 23: Market overview: Americas
Exhibit 24: Hybrid imaging market in Americas 2016-202 ($ millions)
Exhibit 25: Market overview: EMEA
Exhibit 26: Hybrid imaging market in EMEA 2016-2021 ($ millions)
Exhibit 27: Hybrid imaging market in APAC 2016-2021 ($ millions)
Exhibit 28: Market overview: APAC
Exhibit 29: Global hybrid imaging market segmentation by geography 2016-2021 ($ millions)
Exhibit 30: Global hybrid imaging market segmentation by geography 2016-2021 (%)
Exhibit 31: Acceptance of PET/CT and PET scanners worldwide (%)
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Competitive structure analysis of global hybrid imaging market 2016
Exhibit 35: Competitive landscape analysis of global hybrid imaging market 2016
Exhibit 36: Market share analysis of global hybrid imaging market 2016
Exhibit 37: Strategic success factors of companies in global hybrid imaging market
Exhibit 38: GE Healthcare: Key highlights
Exhibit 39: GE Healthcare strength assessment
Exhibit 40: GE Healthcare strategy assessment
Exhibit 41: GE Healthcare opportunity assessment
Exhibit 42: Mediso: Key highlights
Exhibit 43: Mediso strength assessment
Exhibit 44: Mediso strategy assessment
Exhibit 45: Mediso opportunity assessment
Exhibit 46: Philips Healthcare: Key highlights
Exhibit 47: Philips Healthcare strength assessment
Exhibit 48: Philips Healthcare strategy assessment
Exhibit 49: Philips Healthcare opportunity assessment
Exhibit 50: Siemens Healthcare: Key highlights
Exhibit 51: Siemens Healthcare strength assessment
Exhibit 52: Siemens Healthcare strategy assessment
Exhibit 53: Siemens Healthcare opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AGFA Healthcare
  • Carestream Health
  • Cubresa
  • IBA Molecular
  • Nordion
  • Piramal Imaging
  • MORE
New Report Released: – Global Hybrid Imaging Market 2017-2021

The author of the report recognizes the following companies as the key players in the global hybrid imaging market: GE Healthcare, Mediso, Philips Healthcare, and Siemens Healthcare.

Other Prominent Vendors in the market are: Advanced Accelerator Applications, AGFA Healthcare, BC Technical, Cardinal Health, Carestream Health, CMR Naviscan, Cubresa, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, IBA Molecular, Mylin Medical, CMR Naviscan, Nordion, Photo Diagnostic Systems, Piramal Imaging, Positron, RadioMedix, Roses Medical & Surgical Supply, Sofie Biosciences, and Toshiba Medical Systems.

Commenting on the report, an analyst from the research team said: “One trend in market is emergence of time of flight-hybrid image systems. The emergence of time of flight-PET/CT systems is expected to have a positive impact on the market growth, owing to its increased advantages over conventional systems. For instance, conventional PET scanners produce images by observing gamma rays created by radioisotopes injected into the body. On the other hand, time of flight-PET scans measure the time difference between the two rays, which substantially improves the images produced by the scan. Time of flight-PET systems incorporate fast photomultipliers, modern electronics, scintillators with high density, and faster computing power for image reconstruction. This helps in producing accurate and high-quality images for better diagnosis of chronic conditions. The system allows physicians to measure tumor metabolism, which reflects tumor aggressiveness. These systems find applications in the areas of oncology such as lung, esophageal, colon, head and neck cancer, melanomas, and brain tumors. One of the advanced time of flight PET system is Toshiba’s Celesteion, which features 450 ps time of flight resolution. Such advanced systems will have a positive impact on the market growth.”

According to the report, one driver in market is growing adoption of PET/CT hybrid imaging. The market witnesses a growing adoption of PET/CT hybrid imaging technology, owing to its advantages such as early diagnosis, accurate disease staging, and effective response to the treatment of chronic conditions such as cancer. The combined PET/CT scans provide images that pinpoint the anatomic location of metabolic activity of an individual. Also, PET/CT is the gold standard for oncology imaging and vendors are improving the technological capabilities of PET/CT hybrid imaging system. This will further improve the adoption rates worldwide. Some of the new technological capabilities include more precise measurement for better differentiation and measurement of tumors, increased data storage capabilities for oncologists to track tumor developments, and less patient movement. Vendors are also providing low-cost PET/CT hybrid imaging systems like the PET/CT machines at around $1.2 million-$2.3 million. Such advantages increase the adoption rate of PET/CT hybrid imaging systems. Also, PET/CT represents one of the medical imaging modalities with the largest growth.

Further, the report states that one challenge in market is high-cost of hybrid imaging devices coupled with limited reimbursements. The high-cost of hybrid imaging devices will not only hinder the adoption rates but will also drive the physicians to opt for low-cost conventional imaging systems. For instance, the cost of SPECT gamma camera ranges from $0.4 million to $0.6 million, while a PET/CT scanner costs about $2 million. Also, the SPECT/CT machines come with high price tags, which limit the adoption rates, particularly in emerging economies. Another issue for low adoption of SPECT/CT is the lack of CMS reimbursements. Also, the high-cost of hybrid systems allows physicians to adopt low-cost standalone systems. For instance, the cost of a standalone PET scan ranges from $3,000 to $6,000, and the cost of a CT scan ranges from $1,200 to $3,200. A large population in APAC, especially in countries such as India and China, will provide a sizeable demand for PET/CT scanners. However, the high cost of PET scanners can reduce the adoption rate even further, thereby affecting the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • GE Healthcare
  • Mediso
  • Philips Healthcare
  • Siemens Healthcare
  • Advanced Accelerator Applications
  • AGFA Healthcare
  • BC Technical
  • Cardinal Health
  • Carestream Health
  • CMR Naviscan
  • Cubresa
  • Eczacibasi-Monrol Nuclear Products
  • FUJIFILM Holdings
  • IBA Molecular
  • Mylin Medical
  • CMR Naviscan
  • Nordion
  • Photo Diagnostic Systems
  • Piramal Imaging
  • Positron
  • RadioMedix
  • Roses Medical & Surgical Supply
  • Sofie Biosciences
  • Toshiba Medical Systems
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll